Feb 04, 2020
KALY Announces $20 Million LOI to Fund Cannabis Biopharmaceutical Technology
Feb 04, 2020
Nuvaira Announces Chief Financial Officer and Pivotal Study Milestone
Jan 28, 2020
KALY-Kali-Extracts RespRx Could Offer Treatment for Coronavirus Symptoms
Jan 23, 2020
Muscogee (Creek) Nation Department of Health Partners with Respiratory-Focused Medical Clinic and Digital Management Platform
Dec 19, 2019
Horizon Healthcare Services, Inc. Collaborates with HGE Health to help Providers improve the Pulmonary/COPD Health Status of its Members
Dec 18, 2019
Additional Patients Eligible for New COPD Treatment with Expansion of UnitedHealthcare® Coverage
Dec 12, 2019
New Pulmonary Rehabilitation Program is a Breath of Fresh Air for Those With Chronic Lung Disease
Dec 10, 2019
HGE Health to Provide Respiratory / COPD Remote Patient Monitoring Services to Science Management Company's National Client Portfolio of Payer and Healthcare Institutions
Dec 02, 2019
CSA Medical, Inc. Announces European Approval for its RejuvenAir® System for COPD Patients with Chronic Bronchitis
Nov 28, 2019
Sosei Heptares Announces That the COPD Treatment Ultibro® Breezhaler® has been Included in the National Reimbursement Drug List in China
Nov 26, 2019
Footit Medical Grows Its Fisher & Paykel Optiflow High Flow Therapy Airvo 2 Line for COPD Patients
Nov 07, 2019
Grifols introduces AlphaID(TM), a free cheek swab to screen for Alpha-1, the most common genetic form of COPD
Oct 21, 2019
Theravance Biopharma and Mylan to Present New Data on YUPELRI® (revefenacin) at the 2019 CHEST Annual Meeting
Oct 14, 2019
Aclidinium is safe and reduces COPD flare-ups, regardless of recent exacerbations
Oct 14, 2019
Preventing COPD exacerbations during the coldest months may save lives, reduce hospitalizations and alleviate strain on health care resources
Oct 14, 2019
Identification of COPD, asthma and overlap syndrome can be teased out with spirometry following use of bronchodilator
Sep 26, 2019
NuvoAir Respiratory Platform Launches in Mexico
Sep 24, 2019
Bayer, Brigham and Women's Hospital, Massachusetts General Hospital open joint lab for research of new treatments for chronic lung diseases
Sep 16, 2019
Gala Therapeutics Receives FDA Breakthrough Device Designation for the Minimally Invasive RheOx(TM) System for Chronic Bronchitis
Sep 04, 2019
Gala Therapeutics Receives CE Mark for its Minimally Invasive RheOx(TM) System for Chronic Bronchitis